Clinical Trials Logo

Bladder Pain Syndrome clinical trials

View clinical trials related to Bladder Pain Syndrome.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06394830 Not yet recruiting - Clinical trials for Interstitial Cystitis

Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)

Start date: June 2024
Phase: Phase 2
Study type: Interventional

This is an open-label study that will enroll participants with Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS). The study will assess PRN (as needed) dosing of up to 6 intravesical (via catheter) doses of VNX001 (study drug) to treat acute instances of moderate to severe bladder pain over a 14-day period. The main aim of the study is to tally the number of doses and assess pain before and after doses. The study will review the safety and tolerability of VNX001. Participants will need to attend up to seven (7) clinic visits (1 for screening and up to 6 visits for VNX001 dosing) or at least one (1) clinic visit (for a combined screening/dosing visit) and 5 telephone visits over the course of 14 days. Participants will also be asked complete a diary or telephone call each day of the study, in order to record bladder pain, urinary urgency, side effects, and medications taken.

NCT ID: NCT06366269 Not yet recruiting - Clinical trials for Interstitial Cystitis

Acupuncture First for IC/BPS

Start date: June 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn if acupuncture in addition to behavioral changes can better treat in women with bladder pain syndrome (also known as interstitial cystitis) that have not received other treatments. The main question it aims to answer is: Does acupuncture improve pain symptoms on the Interstitial Cystitis Index? Researchers will compare six (6) weeks behavioral management alone to behavioral management and acupuncture. Participants will - complete surveys about their bladder pain symptoms - make behavioral changes that have been shown to improve bladder pain symptoms - attend six (6) weekly acupuncture sessions - attend six (6) weekly physical therapy sessions after finishing acupuncture

NCT ID: NCT06013449 Not yet recruiting - Clinical trials for Interstitial Cystitis

Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations

Start date: July 2024
Phase: N/A
Study type: Interventional

The objective of this study is to test the idea that Pulsed Electromagnetic Field (PEMF) therapy will serve as a safe therapeutic modality that can effectively be administered simultaneously with bladder instillations of a bupivacaine-heparin cocktail to improve the chronic pain and/or associated symptoms of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) patients. The study team will distribute the PEMF device to female adults with IC/BPS who have been prescribed bladder instillations of bupivacaine-heparin to see if PEMF therapy in conjunction with bladder instillations of heparin and bupivacaine may be more effective in reducing pain levels and symptomatology of IC/BPS than instillations alone.

NCT ID: NCT05857020 Not yet recruiting - Chronic Pain Clinical Trials

Auricular Acupressure Therapy for Patients With IC/BPS

IC/BPS
Start date: July 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the feasibility of administering auricular acupressure for patients with interstitial cystitis/bladder pain syndrome (IC/BPS), and evaluating the efficacy of auricular acupressure to reduce pain scores and decrease pain medication usage over time.

NCT ID: NCT04734106 Not yet recruiting - Clinical trials for Interstitial Cystitis

Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis

Start date: July 2024
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of super-concentrated, freeze-dried aloe vera capsules for treatment of interstitial cystitis.